What is the ALK / ROS / EGFR Mutation Analysis by PCR Test?

The ALK, ROS1, and EGFR Mutation Analysis by PCR is a molecular diagnostic test used to detect genetic mutations associated with certain cancers, especially non-small cell lung cancer (NSCLC). These mutations help doctors determine whether a patient may benefit from targeted cancer therapies, which can be more effective and personalized than standard treatments.

Who should take this test?

• Patients diagnosed with non-small cell lung cancer (NSCLC).
• Individuals suspected of having genetic mutations related to cancer.
• Patients undergoing evaluation for targeted cancer therapy.
• People with advanced or metastatic lung cancer.
• Doctor-advised molecular testing for cancer diagnosis and treatment planning.

Preparation & Test Process

How to interpret results

The report indicates whether ALK, ROS1, or EGFR gene mutations are present in the tumor sample.

Mutation detected may indicate eligibility for specific targeted therapies that block cancer growth signals.
No mutation detected may suggest alternative treatment approaches such as chemotherapy or immunotherapy.

Results should always be interpreted by an oncologist along with clinical findings and other diagnostic tests.

FAQs – ALK / ROS / EGFR Mutation Analysis